Skip to main content
. 2021 Jan 29;44(7):1379–1386. doi: 10.1007/s40618-021-01515-6

Fig. 1.

Fig. 1

Risk for mortality for DPP4i users and other glucose-lowering medication users (crude data). Risk ratio with 95% confidence intervals